Alpha-GPC, Explained: The Complete Hub
One molecule, four names
| Name | Where you see it |
|---|---|
| Alpha-GPC | Supplement labels, most articles |
| L-alpha-glycerylphosphorylcholine | The full chemical name, older papers |
| Choline alfoscerate | Research papers, European prescribing |
| Glycerophosphocholine (GPC) | Biochemistry literature |
The guides
- The Alpha-GPC Research Library: all 144 studies, PubMed-linked, evidence-labeled, negative results included. The foundation everything else cites.
- What is Alpha-GPC?: the plain-English explainer and name decoder.
- Benefits, by evidence level: every claimed benefit labeled human RCT, small trial, or petri dish.
- Side effects and safety: both Korean cohorts, the TMAO question, and who should talk to a doctor first.
- Dosage and timing: what the studies actually used, every number cited.
- Alpha-GPC vs citicoline: the comparison written by someone who sells neither.
- Alpha-GPC in pre-workout: why it is on the label vs what the studies measured.
- Alpha-GPC and TMAO: the heart-pathway question, reported straight.
- Alpha-GPC and sleep: what trials actually reported vs community lore.
- Every day, long term: what the longest trials ran, ceilings and cycling.
- How long to work: measured timepoints, not invented minute counts.
- Caffeine and stacks: what is studied together (almost nothing) and what is hypothesis.
- Can garlic block TMAO from choline?: the two literatures connected honestly, form problem included.
Quick answers
What is Alpha-GPC?
Alpha-GPC (L-alpha-glycerylphosphorylcholine, also called choline alfoscerate) is a choline compound: a molecule the body uses as a building block for acetylcholine, a neurotransmitter, and for cell-membrane phospholipids. It is sold as a supplement in North America and has been prescribed for age-related cognitive decline in parts of Europe. It is one of the most-studied choline sources, with research spanning 1986 to 2026.
What are the studied benefits of Alpha-GPC?
The research covers cognition (mostly in clinical populations from its prescription-drug era), athletic power output (small human trials), acute growth-hormone response, and choline delivery mechanisms. The honest headline from our 144-study library: only 5 studies looked at cognition in healthy adults, so the impressive trial results largely come from clinical populations, not from healthy people looking for an edge.
What are Alpha-GPC side effects?
Trials most often report headache, insomnia, and digestive upset, and tolerability in the large clinical trials was generally described as good. Two very large Korean cohort studies reached different conclusions on long-term safety: a 2021 study associated use with higher stroke risk, and a 2025 study in over 500,000 patients found lower dementia conversion and did not reproduce the harm signal in key groups. Both are observational. Our side-effects guide covers both honestly.
How much Alpha-GPC per day do studies use?
The dementia-era clinical trials typically used 1,200 mg per day in divided doses. Athletic studies commonly used around 600 mg taken before exercise. Market capsules commonly come in 300 to 600 mg. Those are study and label facts, not medical advice: talk to a doctor about what fits you, especially if you take medications.
Alpha-GPC vs citicoline (CDP-choline): what is the difference?
Both are choline compounds studied for cognition, but they are different molecules with different research bases. Alpha-GPC delivers a higher share of choline by weight; citicoline contributes cytidine alongside choline. Neither is universally "better": the honest answer depends on the goal, which is why our comparison guide labels the evidence for each instead of declaring a winner.
Is Alpha-GPC the same as choline alfoscerate?
Yes. Alpha-GPC, L-alpha-glycerylphosphorylcholine, choline alfoscerate, and glycerophosphocholine are four names for the same molecule. Supplement labels usually say Alpha-GPC, research papers often say choline alfoscerate or glycerophosphocholine, and European prescribing uses choline alfoscerate.
Educational content about a dietary-supplement ingredient; not medical advice, and no product claims are made or implied. Research is reported at the evidence level it was published at, including studies that found no effect or found safety signals. Maintained by MAXXING Editorial; corrections welcome.
